Patently-O highlights Sarah A. Kagan’s recent IP Alert on the Federal Circuit arguments in Gilead Sciences v. Merck in its article, “An Interesting Pending Appeal Involving Violation of an NDA to Prosecute an Application.”
Click here to read the article.
Click here to read Ms. Kagan’s IP Alert on the case.
Posted: March 28, 2018
